OliX Pharmaceuticals, Inc.
Clinical-stage company developing RNAi therapeutics for dermal and ophthalmic diseases.
226950 | KO
Overview
Corporate Details
- ISIN(s):
- KR7226950004
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 수정구 고등동 608-3 -, 성남시
- Website:
- https://olixpharma.com
- Sector:
- Manufacturing
Description
OliX Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company specializing in the development of therapeutics based on RNA interference (RNAi) technology. The company leverages its proprietary asymmetric siRNA (asiRNA) platform to create treatments that selectively silence disease-causing genes. Its research and development efforts are focused on building a robust pipeline of drug candidates targeting a variety of illnesses with high unmet medical needs. The pipeline has a particular emphasis on ophthalmic and dermal disorders, with key programs addressing conditions such as hypertrophic scars, age-related macular degeneration (AMD), and other fibrotic and ocular diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-03-17 00:00 |
사업보고서 (2022.12)
|
Korean | 1.8 MB | ||
| 2023-03-15 00:00 |
감사보고서제출
|
Korean | 25.1 KB | ||
| 2023-03-15 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 129.3 KB | ||
| 2023-03-10 00:00 |
주주총회소집공고
|
Korean | 417.4 KB | ||
| 2023-03-09 00:00 |
투자판단관련주요경영사항(안드로겐성 탈모가 있는 건강한 남성을 대상으로 OLX72021의 안전성, 내약성 및 약동학적 특성을 평가하기 위한 다기…
|
Korean | 12.1 KB | ||
| 2023-03-06 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 123.1 KB | ||
| 2023-02-27 00:00 |
투자판단관련주요경영사항(GalNAc-asiRNA 기술을 이용한 Option 1종 행사)
|
Korean | 12.2 KB | ||
| 2023-02-24 00:00 |
주주총회소집결의
|
Korean | 12.1 KB | ||
| 2023-02-24 00:00 |
주식매수선택권부여에관한신고
|
Korean | 13.5 KB | ||
| 2023-02-24 00:00 |
[기재정정]주식매수선택권부여에관한신고
|
Korean | 18.9 KB | ||
| 2023-02-24 00:00 |
[기재정정]주식매수선택권부여에관한신고
|
Korean | 19.0 KB | ||
| 2023-02-08 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 12.1 KB | ||
| 2023-02-02 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 144.0 KB | ||
| 2023-01-06 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 127.5 KB | ||
| 2022-12-21 00:00 |
투자판단관련주요경영사항(안드로겐성 탈모가 있는 건강한 남성을 대상으로 OLX72021의 안전성, 내약성 및 약동학적 특성을 평가하기 위한 다기…
|
Korean | 11.2 KB |
Automate Your Workflow. Get a real-time feed of all OliX Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for OliX Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for OliX Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
